Dong-A ST Co., Ltd. 170900.KS Stock
Dong-A ST Co., Ltd. Price Chart
Dong-A ST Co., Ltd. 170900.KS Financial and Trading Overview
Dong-A ST Co., Ltd. stock price | 67300 KRW |
Previous Close | 52600 KRW |
Open | 53000 KRW |
Bid | 52400 KRW x 0 |
Ask | 52500 KRW x 0 |
Day's Range | 52300 - 53000 KRW |
52 Week Range | 46176.47 - 69500 KRW |
Volume | 11.04K KRW |
Avg. Volume | 6.93K KRW |
Market Cap | 446.13B KRW |
Beta (5Y Monthly) | 0.856164 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 700 (1.28%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | 72010 KRW |
170900.KS Valuation Measures
Enterprise Value | 601.35B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.7123919 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.96 |
Enterprise Value/EBITDA | 17.615 |
Trading Information
Dong-A ST Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.856164 |
52-Week Change | -9.97% |
S&P500 52-Week Change | 20.43% |
52 Week High | 69500 KRW |
52 Week Low | 46176.47 KRW |
50-Day Moving Average | 55872 KRW |
200-Day Moving Average | 57148.87 KRW |
170900.KS Share Statistics
Avg. Volume (3 month) | 6.93K KRW |
Avg. Daily Volume (10-Days) | 7.7K KRW |
Shares Outstanding | 8.51M |
Float | 5.55M |
Short Ratio | N/A |
% Held by Insiders | 39.86% |
% Held by Institutions | 14.45% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 117.00% |
Payout Ratio | 0.36180001 |
Last Split Factor | 1.02:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.11% |
Operating Margin (ttm) | 2.08% |
Gross Margin | 49.95% |
EBITDA Margin | 5.45% |
Management Effectiveness
Return on Assets (ttm) | 0.69% |
Return on Equity (ttm) | 2.60% |
Income Statement
Revenue (ttm) | 626.25B KRW |
Revenue Per Share (ttm) | 70869.06 KRW |
Quarterly Revenue Growth (yoy) | -5.89% |
Gross Profit (ttm) | N/A |
EBITDA | 34.14B KRW |
Net Income Avi to Common (ttm) | 19.51B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 342.69% |
Balance Sheet
Total Cash (mrq) | 295.69B KRW |
Total Cash Per Share (mrq) | 28982.5 KRW |
Total Debt (mrq) | 342.71B KRW |
Total Debt/Equity (mrq) | 49.69 KRW |
Current Ratio (mrq) | 2.532 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.55B KRW |
Levered Free Cash Flow (ttm) | -64899571712 KRW |
Profile of Dong-A ST Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 64 Cheonhodaero |
ZIP | N/A |
Phone | 82 2 920 8114 |
Website | https://www.donga-st.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
Q&A For Dong-A ST Co., Ltd. Stock
What is a current 170900.KS stock price?
Dong-A ST Co., Ltd. 170900.KS stock price today per share is 67300 KRW.
How to purchase Dong-A ST Co., Ltd. stock?
You can buy 170900.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dong-A ST Co., Ltd.?
The stock symbol or ticker of Dong-A ST Co., Ltd. is 170900.KS.
Which industry does the Dong-A ST Co., Ltd. company belong to?
The Dong-A ST Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dong-A ST Co., Ltd. have in circulation?
The max supply of Dong-A ST Co., Ltd. shares is 8.65M.
What is Dong-A ST Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Dong-A ST Co., Ltd. PE Ratio is now.
What was Dong-A ST Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Dong-A ST Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Dong-A ST Co., Ltd. company belong to?
The Dong-A ST Co., Ltd. sector is Healthcare.